Composition and Structure of Fluorescent Graphene Quantum Dots Generated by Enzymatic Degradation of Graphene Oxide
Source abstract
Abstract
The wide applications of carbon nanomaterials (CNMs) in both materials and life sciences necessitate investigation of their metabolites due to the inevitable contact of CNMs and biological systems. Graphene oxide (GO), along with other types of CNMs, can be enzymatically degraded by myeloperoxidase (MPO), an enzyme released during the innate immune response. However, enzymatic degradation products are neither well-defined nor well-understood. Some products generated during MPO-catalyzed degradation of GO could emit blue photoluminescence (PL) and were simply dubbed graphene quantum dots (GQDs) without further elucidating their structures. In this work, we use liquid chromatography–mass spectrometry to isolate and elucidate chemical structures of the MPO-catalyzed degradation products. A general chemical formula screening workflow was developed for the GQDs, which are in the form of polyaromatic hydrocarbons (PAHs), obtained in the degradation products. Structures of the PAHs responsible for the blue PL were further proposed using density functional theory calculations. Our results indicated that structures with several conjugated benzene rings are likely to generate the observed PL. This work provides insights into the mechanism of enzymatic degradation and opens opportunities for fluorescence imaging of GO in biological systems.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Carbon and Quantum Dots Applications · Graphene and Nanomaterials Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Pittsburgh, Pittsburgh, Pennsylvania 15260, United States
United States Department of Energy, National Energy Technology Laboratory, Pittsburgh, Pennsylvania 15236, United States
Department of Chemical and Petroleum Engineering, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States
Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, United States
Funding
Division of Chemistry
References (67)
Show source-provided references
1. 10.1002/smll.20110159410.1002/smll.201101594 ↗
2. 10.1126/sciadv.150056410.1126/sciadv.1500564 ↗
3. 10.1002/adma.20180236810.1002/adma.201802368 ↗
4. 10.1021/acsnano.8b0475810.1021/acsnano.8b04758 ↗
5. 10.1539/joh.17-0089-RA10.1539/joh.17-0089-RA ↗
6. 10.1016/j.cbi.2019.04.03610.1016/j.cbi.2019.04.036 ↗
7. 10.1021/ar300106h10.1021/ar300106h ↗
8. 10.1016/j.taap.2016.01.00210.1016/j.taap.2016.01.002 ↗
9. 10.1038/nnano.2010.4410.1038/nnano.2010.44 ↗
10. 10.1002/smll.20150003810.1002/smll.201500038 ↗
11. 10.1039/C7NR03552G10.1039/C7NR03552G ↗
12. 10.1016/j.jhazmat.2009.03.13710.1016/j.jhazmat.2009.03.137 ↗
13. 10.1021/acs.analchem.0c0138010.1021/acs.analchem.0c01380 ↗
14. 10.1021/nn301629v10.1021/nn301629v ↗
15. 10.1002/anie.20120890410.1002/anie.201208904 ↗
16. 10.1002/anie.20090615410.1002/anie.200906154 ↗
17. 10.1021/jp503413s10.1021/jp503413s ↗
18. 10.1021/ja908362310.1021/ja9083623 ↗
19. 10.1016/j.abb.2015.01.02810.1016/j.abb.2015.01.028 ↗
20. 10.1038/s41598-019-50919-110.1038/s41598-019-50919-1 ↗
21. 10.1063/1.150836810.1063/1.1508368 ↗
22. 10.1063/1.217325810.1063/1.2173258 ↗
23. 10.1016/j.theochem.2009.08.01810.1016/j.theochem.2009.08.018 ↗
24. Frisch M. J. · 2016
25. 10.1016/j.cplett.2004.06.01110.1016/j.cplett.2004.06.011 ↗
26. 10.1021/cr990400910.1021/cr9904009 ↗
27. 10.1063/1.47465910.1063/1.474659 ↗
28. 10.1023/A:102252590912810.1023/A:1022525909128 ↗
29. 10.1016/S0021-9258(18)53581-X10.1016/S0021-9258(18)53581-X ↗
30. 10.1021/jasms.9b0007010.1021/jasms.9b00070 ↗
31. 10.1038/nnano.2014.28210.1038/nnano.2014.282 ↗
32. 10.1002/chem.20140628010.1002/chem.201406280 ↗
33. 10.1002/cjoc.20059018510.1002/cjoc.200590185 ↗
34. 10.1016/j.aca.2016.01.03410.1016/j.aca.2016.01.034 ↗
35. 10.1002/mas.1000810.1002/mas.10008 ↗
36. 10.1039/C4MB00586D10.1039/C4MB00586D ↗
37. 10.1002/jms.321810.1002/jms.3218 ↗
38. 10.1007/s13361-017-1626-y10.1007/s13361-017-1626-y ↗
39. 10.1021/jp909284g10.1021/jp909284g ↗
40. 10.1039/C5NP00073D10.1039/C5NP00073D ↗
41. 10.1002/rcm.696810.1002/rcm.6968 ↗
42. 10.1038/ncomms106710.1038/ncomms1067 ↗
43. 10.1002/adfm.20090016710.1002/adfm.200900167 ↗
44. 10.1002/chem.20150311010.1002/chem.201503110 ↗
45. 10.1038/s41699-017-0041-310.1038/s41699-017-0041-3 ↗
46. 10.1021/jo400286710.1021/jo4002867 ↗
47. 10.1021/ja077449d10.1021/ja077449d ↗
48. 10.1016/j.jcis.2007.02.07710.1016/j.jcis.2007.02.077 ↗
49. 10.1016/S0040-4039(01)90069-310.1016/S0040-4039(01)90069-3 ↗
50. 10.1021/nl072090c10.1021/nl072090c ↗
51. 10.1038/ncomms255510.1038/ncomms2555 ↗
52. 10.1038/nchem.28110.1038/nchem.281 ↗
53. 10.1038/nchem.68610.1038/nchem.686 ↗
54. 10.1002/adma.20090199610.1002/adma.200901996 ↗
55. 10.1098/rspa.1932.004710.1098/rspa.1932.0047 ↗
56. 10.1021/jp021152e10.1021/jp021152e ↗
57. 10.1039/C7CP06048C10.1039/C7CP06048C ↗
58. 10.1021/acs.jpcc.1c0081210.1021/acs.jpcc.1c00812 ↗
59. World Health Organization. Regional Office for, E · 2010
60. Working Group on the Evaluation of Carcinogenic Risks to Humans. Some non-heterocyclic polycyclic aromatic hydrocarbons and some related exposures. In IARC Monograph Evaluation Carcinogenic Risks Humans; The International Agency for Research on Cancer: Lyon; 2010, 92, 1–853.
61. 10.1007/s00204-017-2124-510.1007/s00204-017-2124-5 ↗
62. 10.1039/c3tx50022e10.1039/c3tx50022e ↗
63. 10.1007/s00204-017-2068-910.1007/s00204-017-2068-9 ↗
64. 10.1007/s00204-017-1964-310.1007/s00204-017-1964-3 ↗
65. 10.1016/j.taap.2004.11.00610.1016/j.taap.2004.11.006 ↗
66. 10.1016/j.taap.2006.09.01810.1016/j.taap.2006.09.018 ↗
67. US Department of Health and Human Services · 1995